Search Results - Yuankai Shi

The changing landscape of anti-lung cancer drug clinical trials in mainland China from 2005 to 2020 by Qiaofeng Zhong, Yunxia Tao, Haizhu Chen, Yu Zhou, Liling Huang, Xiaohong Han, Yuankai Shi

Connect to this object online.

Single-cell and spatial transcriptomics reveal a high glycolysis B cell and tumor-associated macrophages cluster correlated with poor prognosis and exhausted immune microenvironmen... by Liyuan Dai, Guangyu Fan, Tongji Xie, Lin Li, Le Tang, Haizhu Chen, Yuankai Shi, Xiaohong Han

Connect to this object online.

Validation of the IMPROVE bleeding risk score in Chinese medical patients during hospitalization: Findings from the dissolve-2 study by Zhu Zhang, Zhenguo Zhai, Weimin Li, Xinyu Qin, Jieming Qu, Yuankai Shi, Ruihua Xu, Yuming Xu, Chen Wang

Connect to this object online.

Immunogenicity assessment of elder hepatocellular carcinoma patients after inactivated whole-virion SARS-CoV-2 vaccination by Ruyun Gao, Cuiling Zheng, Mengwei Yang, Liyuan Dai, Chen Chen, Jiarui Yao, Zhishang Zhang, Le Tang, Yuankai Shi, Xiaohong Han

Connect to this object online.

Treatment strategy, overall survival and associated risk factors among patients with unresectable stage IIIB/IV non-small cell lung cancer in China (2015-2017): A multicentre prosp... by Yuankai Shi, Xin Zhang, Gang Wu, Jianping Xu, Yong He, Dong Wang, Cheng Huang, Mingwei Chen, Ping Yu, Yan Yu, Wei Li, Qi Li, Xiaohua Hu, Jinjing Xia, Lilian Bu, Angela Yin, Yigong Zhou

Connect to this object online.

Patient-reported outcomes for the phase 3 FURLONG study of furmonertinib versus gefitinib as first-line therapy for Chinese patients with locally advanced or metastatic EGFR mutati... by Yuankai Shi, Gongyan Chen, Xiang Wang, Yunpeng Liu, Lin Wu, Yanrong Hao, Chunling Liu, Shuyang Zhu, Xiaodong Zhang, Yuping Li, Jiwei Liu, Lejie Cao, Ying Cheng, Hui Zhao, Shucai Zhang, Aimin Zang, Jiuwei Cui, Jian Feng, Nong Yang, Jie Hu, Fei Liu, Yong Jiang, Nan Ge

Connect to this object online.